Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Cantor Fitzgerald
Covington
Mallinckrodt
US Army
Daiichi Sankyo
Julphar
Baxter
Novartis
McKinsey

Generated: August 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021810

« Back to Dashboard
NDA 021810 describes NOVOLOG MIX 50/50, which is a drug marketed by Novo Nordisk Inc and is included in one NDA. There is one patent protecting this drug. Additional details are available on the NOVOLOG MIX 50/50 profile page.

The generic ingredient in NOVOLOG MIX 50/50 is insulin aspart protamine recombinant; insulin aspart recombinant. There are thirty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the insulin aspart protamine recombinant; insulin aspart recombinant profile page.

Summary for NDA: 021810

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;SUBCUTANEOUSStrength50 UNITS/ML;50 UNITS/ML
Approval Date:Aug 26, 2008TE:RLD:No
Patent:► SubscribePatent Expiration:Dec 20, 2017Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 021810



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Novartis
McKesson
Dow
Cantor Fitzgerald
US Department of Justice
Healthtrust
Fish and Richardson
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot